| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 11 |
| 1 | FLUOROURACIL | 9 |
| 2 | FLUOROURACIL CREAM, 0.5% | 9 |
| 3 | LEUCOVORIN CALCIUM | 9 |
| 4 | METHYLPREDNISOLONE | 9 |
| 5 | METHYLPREDNISOLONE SODIUM SUCCINATE | 9 |
| 6 | PALONOSETRON HYDROCHLORIDE | 9 |
| 7 | PALONOSETRON | 7 |
| 8 | ARIPIPRAZOLE | 4 |
| 9 | OLANZAPINE PAMOATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOTHIXENE | 1 | 0.0046 |
| 1 | PALONOSETRON HYDROCHLORIDE | 9 | 0.0017 |
| 2 | LEUCOVORIN CALCIUM | 9 | 0.0005 |
| 3 | METHYLPREDNISOLONE SODIUM SUCCINATE | 9 | 0.0002 |
| 4 | OXALIPLATIN | 11 | 0.0001 |
| 5 | RAMELTEON | 1 | 0.0001 |
| 6 | FLUOROURACIL CREAM, 0.5% | 9 | 0.0001 |
| 7 | FLUOROURACIL | 9 | 0.0001 |
| 8 | OLANZAPINE PAMOATE | 4 | 0.0001 |
| 9 | METHYLPREDNISOLONE | 9 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 11 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 2 | Atypical Antipsychotic [EPC] | 4 |
| 3 | Benzodiazepine [EPC] | 3 |
| 4 | Central Nervous System Stimulant [EPC] | 3 |
| 5 | Opioid Agonist [EPC] | 2 |
| 6 | Typical Antipsychotic [EPC] | 2 |
| 7 | Anti-IgE [EPC] | 1 |
| 8 | Antirheumatic Agent [EPC] | 1 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Typical Antipsychotic [EPC] | 2 | 0.0001 |
| 1 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 3 | Central Nervous System Stimulant [EPC] | 3 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 5 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Anti-IgE [EPC] | 1 | 0.0000 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 8 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 4 | 0.0000 |